Stockreport

OncoMed Announces Third Quarter 2018 Financial Results and Operational Highlights

ONCOMED PHARMACEUTICALS  (OMED) 
Last oncomed pharmaceuticals earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: oncomed.com/invest/index.cfm
PDF  -Company continues enrollment in Phase 1b navicixizumab trial following encouraging single agent and interim combination results in ovarian cancer;  -Prepares for pres [Read more]